- 5.2Impact Factor
- 10.5CiteScore
- 16 daysTime to First Decision
Advances and Breakthroughs in Stem Cell Research
This special issue belongs to the section “Stem Cells“.
Special Issue Information
Dear Colleagues,
This Special Issue will center around the latest cutting-edge breakthroughs in stem cell research within immunotherapy and regenerative medicine. In recent years, advancements in stem cell research have opened promising avenues for treating and potentially curing diverse conditions such as cancers, metabolic disorders, and neurodegenerative diseases. The immense potential of specific human iPSC-derived cell lineages, including CAR T cells, CAR NK cells, neurons, cardiomyocytes, and pancreatic islets, holds transformative possibilities in revolutionizing medical practices through the development of innovative therapies. This Special Issue will explore a range of topics related to stem cell therapy, encompassing iPSC (induced pluripotent stem cell)- or hematopoietic-stem-cell-derived, therapeutically relevant lineages. We welcome original manuscripts and reviews that delve into these subjects, contributing to a more profound comprehension of recent advancements and challenges in these domains.
Prof. Dr. Alexander E. Kalyuzhny
Dr. Hemant Kumar Mishra
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stem cell
- induced pluripotent stem cell
- iPSC
- hematopoietic stem cell
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

